Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Söderbergh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Occupational Medicine (Oxford, England)|March 11, 2005
Occupational molybdenum exposure and a gouty electricianAnders I Seldén, N Peter Berg, Annika Söderbergh, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 30, 2006
Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndromeAnnika Söderbergh, Jan Gustafsson, Olov Ekwall, et al.
Frontiers in Immunology|June 22, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitidesErik Hellbacher, Ann Knight, Peter Hemmingsson, et al.
BMC Psychiatry|October 23, 2023
Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)Susanne Bejerot, Daniel Eklund, Hugo Hesser, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type IAnnika Söderbergh, Anne Grethe Myhre, Olov Ekwall, et al.
ACR Open Rheumatology|March 4, 2025
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical PhenotypesHanna Lindberg, Ann Knight, Erik Hellbacher, et al.
Rheumatology (Oxford, England)|April 2, 2023
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitisDiana Ekman, Bengt Sennblad, Ann Knight, et al.
RMD Open|April 5, 2024
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR studyVioletta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, et al.
Rheumatology (Oxford, England)|December 10, 2021
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCAJohanna Dahlqvist, Diana Ekman, Bengt Sennblad, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Occupational Medicine (Oxford, England)|March 11, 2005
Occupational molybdenum exposure and a gouty electricianAnders I Seldén, N Peter Berg, Annika Söderbergh, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 30, 2006
Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndromeAnnika Söderbergh, Jan Gustafsson, Olov Ekwall, et al.
Frontiers in Immunology|June 22, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitidesErik Hellbacher, Ann Knight, Peter Hemmingsson, et al.
BMC Psychiatry|October 23, 2023
Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)Susanne Bejerot, Daniel Eklund, Hugo Hesser, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type IAnnika Söderbergh, Anne Grethe Myhre, Olov Ekwall, et al.
ACR Open Rheumatology|March 4, 2025
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical PhenotypesHanna Lindberg, Ann Knight, Erik Hellbacher, et al.
Rheumatology (Oxford, England)|April 2, 2023
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitisDiana Ekman, Bengt Sennblad, Ann Knight, et al.
RMD Open|April 5, 2024
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR studyVioletta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, et al.
Rheumatology (Oxford, England)|December 10, 2021
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCAJohanna Dahlqvist, Diana Ekman, Bengt Sennblad, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Pageof 2